Mydecine Innovations Group Inc C.MYCO

Alternate Symbol(s): MYCOF

Mydecine Innovations Group Inc. is a Canada-based biotechnology company. The Company is engaged in developing medications and therapies to address mental health disorders, such as nicotine addiction and posttraumatic stress disorder (PTSD). The Company conducts research and development on second generation compounds in Canada with a focus on developing and commercializing psychedelic-inspired regulated medicines. The Company has two lead 3,4-Methylenedioxymethamphetamine (MDMA) candidates. The Company is channeling its MYCO-005, MYCO-006, and MYCO-007 families of patent-pending second-generation MDMA and Psilocybin analogs through Applied Pharmaceutical Innovation (API). It utilizes artificial intelligence (AI) and pharma research infrastructure at the University of Alberta to develop and manufacture new medications to make them accessible to the general public upon Health Canada and Food and Drug Administration (FDA) approval.

CSE:MYCO - Post by User

Mydecine Innovations Group Inc > 35mil shares at 5 cents pp come

<< Previous

Bullboard Posts

Next >>

Comment by CaptainConnon Jan 05, 2021 1:23pm

159 Views

Post# 32224719

RE:RE:RE:35mil shares at 5 cents pp come

Agreed. Buy at support levels strategically and do not listen to goofs. I do believe the SP will continue to bleed lower until volume comes back in but this hysteria about 35 million shares is nonsense. They are in the process of selling their product, uplisting on LSE and starting phase 3 trials late 2021. Hop on for the ride but do not expect all green all the time.

<< Previous

Bullboard Posts

Next >>

Global Tungsten Market and Supply Security